Screener
Azenta AZTA Cumulative Gross Losses and Impairments
Cumulative Gross Losses and Impairments at other companies
Other financials
Where this comes from
Reported directly by Azenta in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Azenta’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054295
| Line item | Sample Management Solutions | Multiomics | Total |
|---|---|---|---|
| Balance - September 30, 2025 | $505,635 | $196,760 | $702,395 |
| Acquisition of UK Biocentre | 1,207 | — | 1,207 |
| Impairment | (36,647) | (112,436) | (149,083) |
| Currency translation adjustments | (7,062) | — | (7,062) |
| Balance - June 30, 2026 | $463,133 | $84,324 | $547,457 |
| Accumulated goodwill impairments, June 30, 2026 | $(36,647) | $(112,436) | $(149,083) |
Item 1. Financial Statements
FAQ
- What is Azenta's cumulative gross losses and impairments?
- Azenta (AZTA) reported cumulative gross losses and impairments of $149.08M in Q2 2026.
- What does cumulative gross losses and impairments mean?
- This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.
Ask your AI about Azenta's cumulative gross losses and impairments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude